Intracranial aneurysm
Conditions
Interventions
None listed
Sponsors
Kobe City Medical Center General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patient who is scheduled or completed to endovascular treatment for intracranial aneurysm using PulseRider or W-EB
Exclusion criteria
Exclusion criteria: no limitation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| complete occlusion without aneurysm rupture and re-treatment at 1 year after treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 neurological death within 30 days after treatment 2 major stroke within 30 days after treatment 3 complete occlusion without aneurysm rupture and re-treatment at 3 years after treatment 4 aneurysm rupture or re-treatment within 3 years after treatment 5 aneurysm recanalization or growth within 3 years after treatment 6 re-treatment within 3 years after treatment 7 major stroke in the territory within 3 years after treatment 8 hemorrhagic event or device failure within 3 years after treatment | — |
Countries
Japan
Contacts
Public ContactChiaki Sakai
Kobe City Medical Center General Hospital Center for Clinical Research and Innovation
Outcome results
None listed